In an industry where every claim needs a source and every process must be auditable, scattered data isn’t just a technical problem. It’s a regulatory risk.
Veltech connects your organization’s knowledge so AI answers with traceability, not just probability.
·
Traceability by design
·
Auditable AI
·
EMA · FDA · GxP
Certified partners
The core challenge
In pharma, AI can’t give probable answers. It has to give traceable ones
Generating answers isn’t the problem; any model can do that. The problem is that in a regulated environment, every claim needs a source, every process needs an audit trail, and every decision has to be explainable. That isn’t an AI problem. It’s a data problem.
Research and development
Scattered experimental knowledge doesn’t scale
Clinical trial data, scientific literature, and lab results sit in separate systems. Scientists spend more time searching than discovering. With a [knowledge graph], scientific questions get real context.
Regulatory affairs
Agency submissions take months of manual consolidation
CTD, PSUR, DSUR. Every dossier requires consolidating data from multiple systems with full traceability. A [governed data platform] turns that consolidation into a continuous process, not a sprint before every submission.
Manufacturing and quality
Process data isn’t connected to product quality data
Without that connection, deviation investigations and CAPAs are labor-intensive, and the link between process parameters and quality attributes has to be rebuilt every time.
Enterprise AI
AI agents answer fluently, but not traceably
In a GxP environment, an answer that can’t be cited isn’t valid, not for scientists and not for regulators. [Governed AI agents] change that.
A real case from our portfolio
Generating answers wasn’t the problem; the models were already doing that. The problem was that those answers were probable, not traceable, and in a regulated industry that isn’t enough. We modeled the organization’s explicit knowledge as a [graph]: which source supports which claim, which regulatory relationship connects each data point. The result wasn’t faster AI, but AI that could show where every answer came from.
Consulting project in the pharmaceutical industry · Veltech
Why pharma is different
Three reasons the data standard in this industry is higher
01
Traceability isn’t optional: it’s regulatory
ALCOA+, 21 CFR Part 11, Annex 11. Data must be attributable, legible, contemporaneous, original, and accurate. Not as an aspiration, but as an inspection requirement.
02
The drug lifecycle generates data volumes few industries can match
From molecule to market: preclinical, Phase I/II/III trials, regulatory approval, post-market pharmacovigilance. Each phase generates different data that must be connected without losing the context of the phases before it.
03
A data error isn’t a technical incident: it’s a risk to patients
That’s why [data governance] isn’t an IT priority. It’s a business priority and a matter of regulatory accountability.
Regulatory framework
Designed for what regulators already require
Data architecture and governance are designed around these frameworks from day one, not added as a layer at the end.
EMA / FDA
Data traceability for marketing authorization dossiers and pharmacovigilance reports (PSUR, DSUR).
GxP
GMP, GCP, GLP: data integrity across manufacturing, clinical trials, and laboratory research.
21 CFR Part 11 · Annex 11
System validation and audit trails for electronic records in regulated environments.
GDPR
Management of clinical trial subject and patient data, with full traceability of access and processing.
RECORDED WEBINAR
Graphs for business: from siloed data to competitive advantage
Discover how graphs organize enterprise data and give you full visibility across your business.
Frequently asked questions
Before you request the assessment
NEXT STEP
Discover how to turn your organization’s knowledge into explainable AI
A no-obligation initial assessment, tailored to your area and where you are today in data maturity.